BioXcel Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q2 2024.
  • BioXcel Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was 177 %.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2023 was 1.87K %.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2022 was -118 %, a 154% decline from 2021.
  • BioXcel Therapeutics, Inc. annual Return On Equity for 2021 was -46.4 %, a 21.8% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 177 +486 Apr 1, 2024 Jun 30, 2024
Q1 2024 374 +552 Jan 1, 2024 Mar 31, 2024
Q4 2023 1.87K +1.99K Oct 1, 2023 Dec 31, 2023
Q3 2023 -891 -813 -1048% Jul 1, 2023 Sep 30, 2023
Q2 2023 -309 -250 -422% Apr 1, 2023 Jun 30, 2023
Q1 2023 -178 -129 -268% Jan 1, 2023 Mar 31, 2023
Q4 2022 -118 -71.6 -154% Oct 1, 2022 Dec 31, 2022
Q3 2022 -77.6 -32.6 -72.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -59.2 -13.9 -30.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -48.3 +7.83 +14% Jan 1, 2022 Mar 31, 2022
Q4 2021 -46.4 +13 +21.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -45 +29.3 +39.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -45.3 +69.2 +60.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -56.1 +46.2 +45.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -59.4 +51.6 +46.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -74.2 +22.9 +23.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -115 -36.8 -47.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -102 -49.1 -92.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -111 -69.7 -169% Oct 1, 2019 Dec 31, 2019
Q3 2019 -97.1 -57 -142% Jul 1, 2019 Sep 30, 2019
Q2 2019 -77.7 Apr 1, 2019 Jun 30, 2019
Q1 2019 -53.2 Jan 1, 2019 Mar 31, 2019
Q4 2018 -41.3 Oct 1, 2018 Dec 31, 2018
Q3 2018 -40.1 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.